Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia.

Hematology. American Society of Hematology. Education Program - 1 Jan 2013

Schlenk Richard F, Döhner Hartmut

Abstract excerpt

In recent years, research in genomics has resulted in the rapid uncovering of the molecular pathogenesis of acute myeloid leukemia (AML). The identification of the genetic determinants of response to standard-but also to experimental-treatment is increasingly used for patient counseling, to guide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Decision Making
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Share to Prognosis

Share to Retinoids in leukemia and cellular processes

Source

Identifiers

PMID: 24319199
DOI: 10.1182/asheducation-2013.1.324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24319199-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia.PMID 24319199Read ↗

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?Semantic proximity Read ↗

The genomic landscape of acute myeloid leukemia: Redefining classifications, ontogeny, and therapeutic strategies.Semantic proximity Read ↗

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.Semantic proximity Read ↗

AML genomics for the clinician.Semantic proximity Read ↗

Toward Individualized Therapy in Acute Myeloid Leukemia: A Contemporary Review.Semantic proximity Read ↗

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapiesSemantic proximity Read ↗

Molecular genetic pathways as therapeutic targets in acute myeloid leukemia.Semantic proximity Read ↗

Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.Semantic proximity Read ↗

Genetic mutations in acute myeloid leukemia that influence clinical decisions.Semantic proximity Read ↗

Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.Semantic proximity Read ↗

A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.Semantic proximity Read ↗

Dissecting the Genetic and Non-Genetic Heterogeneity of Acute Myeloid Leukemia Using Next-Generation Sequencing and In Vivo ModelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.